Press Office
- European Investment Bank
- Communication Department
- 98-100, boulevard Konrad Adenauer
- L-2950 Luxembourg
- Luxembourg
The European Investment Bank (EIB) is providing venture debt financing to Belgian medical-technology company Nyxoah €37.5 million to develop treatments against obstructive sleep apnea. This transaction aligns with the EIB’s priority objective to boost research and technological innovation, in line with the implementation of EU policies.
The European Investment Fund (EIF) and the NATO Innovation Fund (NIF) signed a Memorandum of Understanding (MoU) to cooperate in supporting the long-term growth of the defence, security, and resilience sectors across Europe. The EIF is part of the European Investment Bank (EIB) Group and the NIF is a standalone venture-capital fund backed by 24 NATO countries.
The European Investment Bank (EIB) Group inaugurated an IT Centre of Excellence (CoE) in Warsaw to expand the group’s cloud, cybersecurity and other digital capabilities.